Virus-specific T cells for therapy--approaches, problems, solutions.

Area of Science:

• Immunology
• Cellular Therapy
• Oncology

Background:

• Adoptive T cell therapy involves transferring T cells to patients for disease treatment.
• It is primarily used for viral infections and malignancies, including virus-associated tumors.
• T cells can be autologous or allogeneic, and recent research focuses on antigen-specific T cells.

Purpose of the Study:

• To provide an overview of approaches, challenges, and solutions in adoptive T cell therapy.
• To highlight the success and areas for improvement in treating herpesviral diseases post-transplantation.

Main Methods:

• Review of selected approaches in adoptive T cell therapy.
• Focus on challenges and solutions in the context of herpesviral disease treatment.

Main Results:

• Adoptive T cell therapy is effective for various conditions, including viral infections and cancers.
• T cell preparations can vary in specificity (monoclonal to polyclonal) and selection criteria (specificity, function, proliferation, surface markers).
• Herpesviral disease in post-transplant patients remains an area with significant potential for improvement.

Conclusions:

• Adoptive T cell therapy is a promising treatment modality with diverse applications.
• Optimizing T cell selection and preparation is crucial for therapeutic success.
• Further research is needed to enhance adoptive T cell therapy for herpesviral diseases in transplant recipients.